Remove clinical cardiovascular-health
article thumbnail

First NICE-recommended treatment for chronic heart failure

European Pharmaceutical Review

Final draft guidance has been published for the first National Institute for Health and Care Excellence (NICE)-recommended treatment for symptomatic chronic heart failure with preserved or mildly reduced ejection fraction. The study enrolled 6,263 randomised patients. This was reported as 16.4 percent in the dapagliflozin group and 19.5

Medicine 102
article thumbnail

Acoustic Stimulation for Insomnia

Medgadget

Insomnia is not just unpleasant, but can have significant long-term health consequences, including an increased risk of cardiovascular disease, obesity, and diabetes. This is not just unpleasant and tiring, but can have significant long-term health implications, highlighting the importance of sleep for overall health.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Johnson & Johnson to Acquire Heart Pump Maker Abiomed

Legacy MEDSearch

per share in cash if certain commercial and clinical milestones are achieved. The transaction broadens Johnson & Johnson MedTech’s (JJMT) position as a growing cardiovascular innovator, advancing the standard of care in one of healthcare’s largest unmet need disease states: heart failure and recovery. About Johnson & Johnson.

article thumbnail

Wearable Ultrasound for Deep Tissue Monitoring

Medgadget

“The sensor can evaluate cardiovascular function in motion. For healthy populations, our device can measure cardiovascular responses to exercise in real time and thus provide insights into the actual workout intensity exerted by each person, which can guide the formulation of personalized training plans.”

Training 126
article thumbnail

Powering Rapid Cognitive Analysis with AI

Impetus Digital

Tom Sawyer , CFO at Cognetivity Neurosciences , sat down with me to discuss the benefits of AI-driven dementia detection technology for patients, health care providers, and clinical research. The clinical tool is on iPads. It’s not looked after in the same way that the cardiovascular system is.

article thumbnail

Eko Launches SENSORA™ Cardiac Disease Detection Platform

Legacy MEDSearch

Eko , a digital health company applying artificial intelligence (AI) in the fight against heart and lung disease, today announced the launch of the SENSORA Cardiac Disease Detection Platform. Older adults have a 1 in 10 chance of developing clinically significant VHD.

article thumbnail

Health Innovators – Dr. Houda Hachad

pharmaphorum

Houda Hachad is vice president of clinical operations at AccessDx Laboratory, where she focuses on expanding the use of pharmacogenomic testing, a major piece of the puzzle for precision medicine. And that same technology and approach can also be of benefit to other chronic conditions, from cardiovascular disease to behavioural health.